Previous 10 | Next 10 |
Gainers : Neuralstem (NASDAQ: CUR ) +69% . IVERIC (NASDAQ: ISEE ) +50% . Big 5 Sporting Goods (NASDAQ: BGFV ) +31% . Clearside Biomedical (NASDAQ: CLSD ) +23% . OneSpan (NASDAQ: OSPN ) +20% . MutualFirst Financial (NASDAQ: MFSF ) +20% . Cellect Biotechnology (NASDAQ: APOP ) +21...
Vocera Communications (NYSE: VCRA ) -27% on Q3 earnings . More news on: Vocera Communications, Inc., Melinta Therapeutics, Inc., BeyondSpring Inc., Stocks on the move, Read more ...
Cellect Biotechnology (NASDAQ: APOP ) +43% after reverse split & ADS ratio change. More news on: Cellect Biotechnology Ltd., PDS Biotechnology Corporation, Genocea Biosciences, Inc., Stocks on the move, Read more ...
Cellect Biotechnology (NASDAQ: APOP ): Q2 GAAP EPADS of -$0.02. More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...
TEL AVIV, Israel , Aug. 13, 2019 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today reported financial and operating results for the second quarter ended June 30, 2019 and provided a...
APOP stock is having a solid day with a gain of over 100% after Cellect Biotechnology Ltd. (NASDAQ:APOP) reported positive results from its ongoing Phase 1/2 clinical study of ApoGraft. Solid News One stock that has gone on an impressive rally this morning is Israel-based biotechnology ...
Cellect Biotechnology (NASDAQ: APOP ) is up 47% premarket after the Data and Safety Monitoring Board (DSMB) reviewed the safety data from its ongoing Phase 1/2 clinical study of ApoGraft, and recommended dose escalation and the continuation of enrollment for the fourth and fina...
TEL AVIV, Israel , Aug. 12, 2019 /PRNewswire/ -- Following the one month data of the 9 th patient, the Data and Safety Monitoring Board (DSMB) reviewed the safety data from Cellect Biotechnology Ltd.'s (Nasdaq: APOP) ongoing Phase 1/2 clinical study of ApoGraft™, and announc...
Thinly traded nano cap Cellect Biotechnology Ltd. ( APOP +25.5% ) is up on almost an 8x surge in volume, albeit on turnover of only 523K shares, on no readily available news. More news on: Cellect Biotechnology Ltd., Healthcare stocks news, Stocks on the move, Read more ...
TEL AVIV, Israel and ST. LOUIS, Missouri , July 8, 2019 /PRNewswire/ -- As the two organizations move closer to the commencement of the clinical trial to determine the safety and tolerability of the Apograft technology for bone marrow transplantations, Cellect Biotechnology Lt...
News, Short Squeeze, Breakout and More Instantly...
Cellect Biotechnology Ltd. Company Name:
APOP Stock Symbol:
NASDAQ Market:
Tel Aviv , Oct. 15, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: “APOP”) (the “Company”), announced today the record date and distribution date for the contingent value rights (the “CVRs”) to be distributed in connection with the...
Cellect Biotechnology Ltd (NASDAQ: APOP) shareholders approved the previously announced strategic merger agreement with Quoin Pharmaceuticals, the company said in a press release on Monday. Shares of the Israel-headquartered firm jumped about 50% this morning. The stock has now ...